Thus, the observed numerical prolongation of PFS with combination therapy did not reach statistical significance.
← all excerpts
Efficacy and safety of nab-paclitaxel plus PD-1 inhibitor in elderly patients with advanced squamous lung cancer.
1
—
—
Thus, the observed numerical prolongation of PFS with combination therapy did not reach statistical significance.